Huawei and Qualcomm have signed a multi-year patent licensing agreement covering 5G, artificial intelligence, computing and networking, with Qualcomm also set to purchase a slice of Huawei's US patents in the same technology areas.

The arrangement gives both companies access to each other's patent portfolios across a range of technology fields. Closing of the patent sale depends on the usual regulatory approvals, the two companies said on Tuesday.

The deal sits alongside, rather than replaces, the wider licensing track that defines the modern mobile industry: standard-essential patents (SEPs) on 4G and 5G, licensed under FRAND terms.

What does the deal actually cover?

The licensing pact spans 5G, AI, computing and networking. Separately, Qualcomm will acquire certain Huawei US patents covering compute, AI, networking and other technologies — a portfolio carve-out aimed at the American market.

Both sides framed the agreement as a recognition of each other's research output. Huawei Chief Intellectual Property Officer Alan Fan said: "This agreement not only demonstrates the value of Huawei's innovations, but also recognises Qualcomm's foundational contributions to modern communication technologies."

Fan added that Huawei's "decades of sustained investment in fundamental R&D" and its "near-physical-limit signal transmission technology using polar codes" for 5G had cemented its standing in mobile communications.

Why does the Qualcomm side see value in this?

Qualcomm Technology Licensing Executive Vice President and General Manager John Han pitched the deal in terms of his company's 5G SEP programme. "This agreement reaffirms industry recognition of Qualcomm's 5G technology leadership and the success of Qualcomm's 5G SEP licensing program," Han said.

His counterpart at Huawei extended the same courtesy back: the agreement, Han said, "likewise reflects Qualcomm's recognition of Huawei's continued innovation and intellectual property in 5G and other technology fields."

Where does the regulatory friction sit?

The transaction remains contingent on regulatory approvals, with both companies declining to name the jurisdictions that will review it. Huawei's US patent transactions have a complicated history, shaped by US export controls and entity-list restrictions imposed on the Chinese vendor since 2019.

A Qualcomm purchase of US-filed Huawei patents in compute, AI and networking cuts a narrower path through those controls than a broader cross-border assignment would. The deal's structure — patent sale plus licence, rather than outright portfolio transfer — is consistent with the carve-out model other Chinese patent holders have used in the US market.

What does this signal for the wider SEP market?

The pact extends a pattern of bilateral 5G SEP settlements between the largest Chinese and US patent holders. Such agreements tend to stabilise royalty flows before they reach courts or arbitration panels, and they have become a recurring feature of the post-5G-standards landscape.

Both companies said the deal demonstrates their commitment to FRAND licensing practices — the framework that underpins 3GPP standardisation and that courts in the US, UK, China and India have repeatedly enforced.

What happens next?

The companies have set no public closing date. With regulatory clearances still pending, the financial terms of both the licence and the US patent sale remain undisclosed. Industry watchers will look for confirmation of the deal closing and any subsequent disclosures on royalty scope before treating the agreement as a benchmark for future Huawei or Qualcomm SEP negotiations.